Skin eruptions in children: Drug hypersensitivity vs viral exanthema
- 23 February 2021
- journal article
- review article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 32 (5), 824-834
- https://doi.org/10.1111/pai.13485
Abstract
Childhood rashes or exanthemas are common and are usually relatively benign. There are many causes of rash in children, including mainly viruses, and less often bacterial toxins, drugs, allergens and other diseases. Viral exanthema often appears while children are taking a medication in the course of a viral infection; it can mimic drug exanthema and is perceived as a drug allergy in 10% of cases. In the vast majority of cases, the distinction between virus‐induced and drug‐induced skin eruption during the acute phase is not possible. The drugs most commonly implicated are beta‐lactams (BL) and non‐steroidal anti‐inflammatory drugs (NSAIDs). Viruses, commonly Epstein‐Barr virus (EBV), human herpesvirus 6 (HHV6) and cytomegalovirus (CMV), and the bacterium, Mycoplasma pneumoniae, may cause exanthema either from the infection itself (active or latent) or because of interaction with drugs that are taken simultaneously. Determination of the exact diagnosis requires a careful clinical history and thorough physical examination. Haematological and biochemical investigations and histology are not always helpful in differentiating between the two types of exanthema. Serological and polymerase chain reaction (PCR) assays can be helpful, although a concomitant acute infection does not exclude drug hypersensitivity. A drug provocation test (DPT) is although considered the gold standard for the diagnosis and is not preferred by the patients. Skin tests are not well tolerated, and in vitro tests, such as the basophil activation test and lymphocyte transformation, are of low sensitivity and specificity and their relevance is debatable. Based on current evidence, we propose a systematic clinical approach for timely differential diagnosis and management of rashes in children who present a cutaneous eruption while receiving a drug.Keywords
This publication has 103 references indexed in Scilit:
- Skin manifestations of drug allergyBritish Journal of Clinical Pharmacology, 2011
- Fas-ligand staining in non-drug- and drug-induced maculopapular rashesJournal of Cutaneous Pathology, 2010
- Staphylococcal Toxic Shock Syndrome Erythroderma Is Associated with Superantigenicity and HypersensitivityClinical Infectious Diseases, 2009
- Virale Exanthemerkrankungen bei Kindern. Teil 3: Parainfektiöse Exanthemerkrankungen und Exanthemerkrankungen, die auf Interaktionen von Virusinfektionen und Arzneimitteln zurückzuführen sindJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2009
- Viral exanthems in childhood. Part 3: Parainfectious exanthems and those associated with virus‐drug interactionsJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2009
- Virale Exanthemerkrankungen bei Kindern â Infektiöse (direkte) Exanthemerkrankungen. Teil 1: Klassische ExanthemeJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2009
- Viral exanthems in childhood – infectious (direct) exanthems. Part 1: Classic exanthemsJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2009
- Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugsAllergy, 2008
- CD69 upregulation on T cells as an in vitro marker for delayed‐type drug hypersensitivityAllergy, 2008
- Gianotti-Crosti syndrome: A retrospective analysis of 308 casesJournal of the American Academy of Dermatology, 1992